Pharmaceutical firms grappling with 2003 sales target

Published: 2003-10-06 07:00:00

Updated: 2003-10-06 07:00:00

As the overall sales target rate of leading domestic pharmaceutical firms has remained at 80 to 90 percent by the third quarter of this year amid lingering business slump, more and more pharmaceutical firms are planning to undertake their aggressive marketing for OTC products to meet their sales ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK